Cancer Diagnosis Increases Risk of Guillain-Barré Syndrome: Study
Patients with lymphomas, prostate, lung or breast cancer diagnoses had an even higher risk of Guillain-Barré Syndrome than other cancer patients.
Tag Archives: Guillain-Barre Syndrome
-
-
Shingrix Shingles Vaccine Recommended for Immunocompromised Adults: CDC Reports
The previously-used vaccine, Zostavax, was contraindicated for use in immunocompromised adults and involved live virus, unlike the Shingrix shingles vaccine.
-
Shingrix Guillain-Barré Syndrome Risk Seen During 42 Days After Shingles Vaccination: Study
Researchers say the risk-benefit profile of Shingrix still favors it being used as a shingles vaccine.
-
Guillain–Barré Syndrome Warning to be Added to Johnson & Johnson COVID-19 Vaccine
-
Shingrix Vaccine’s Risk of Guillain-Barré Syndrome Results in New FDA Warning
